Your browser doesn't support javascript.
loading
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study.
Chari, Ajai; Rodriguez-Otero, Paula; McCarthy, Helen; Suzuki, Kenshi; Hungria, Vania; Sureda Balari, Anna; Perrot, Aurore; Hulin, Cyrille; Magen, Hila; Iida, Shinsuke; Maisnar, Vladimir; Karlin, Lionel; Pour, Ludek; Parasrampuria, Dolly A; Masterson, Tara; Kosh, Michele; Yang, Shiyi; Delioukina, Maria; Qi, Ming; Carson, Robin; Touzeau, Cyrille.
Afiliação
  • Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Rodriguez-Otero P; Clínica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain.
  • McCarthy H; Royal Bournemouth Hospital, Bournemouth, UK.
  • Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Hungria V; Clinica Medica São Germano, São Paulo, Brazil.
  • Sureda Balari A; Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain.
  • Perrot A; CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France.
  • Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.
  • Magen H; Department of Hematology Chaim Sheba Medical Center, Ramat-Gan, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Maisnar V; 4th Department of Medicine - Haematology, Charles University Hospital, Hradec Králové, Czech Republic.
  • Karlin L; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
  • Pour L; University Hospital Brno, Brno, Czech Republic.
  • Parasrampuria DA; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Masterson T; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Kosh M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Yang S; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Delioukina M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Qi M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Carson R; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Touzeau C; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
Br J Haematol ; 192(5): 869-878, 2021 03.
Article em En | MEDLINE | ID: mdl-33216361
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Imunoterapia / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Imunoterapia / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos